Colgate Palmolive (India) Limited vs Gillette India Limited
An objective side-by-side of COLPAL and GILLETTE, both in Personal Care - Multinational: valuation, profitability, growth, balance sheet, ownership and share-price performance. Where one number is clearly better on its own terms (lower P/E, higher ROE), it is shaded. That is a description, not a recommendation.
At a glance
- Colgate Palmolive (India) Limited is the larger company by market value, about 1.9 times the size of Gillette India Limited.
- On trailing earnings, Colgate Palmolive (India) Limited trades at the lower P/E (34.6 against 36.4).
- Colgate Palmolive (India) Limited earns the higher return on equity (84.2% against 70.6%).
- Over three years Gillette India Limited has grown profits faster (31% a year against 8%).
- Over the past year the share prices returned -20.4% (COLPAL) and -14.2% (GILLETTE).
| Metric | Colgate Palmolive COLPAL |
Gillette India GILLETTE |
|---|---|---|
| Size and price | ||
| Market cap | ₹47,054 Cr | ₹24,343 Cr |
| Share price | ₹1,730.00 | ₹7,470.50 |
| Valuation | ||
| P/E | 34.56 | 36.42 |
| P/B | 29.09 | 25.71 |
| EV/EBITDA | 24.68 | 25.34 |
| PEG | 4.32 | 1.17 |
| Dividend yield | 3.0% | 1.6% |
| Profitability | ||
| ROE | 84.2% | 70.6% |
| ROCE | 108.0% | 91.0% |
| Operating margin | 29.9% | 30.3% |
| Sales (TTM) | ₹6,390 Cr | ₹3,176 Cr |
| Net profit (TTM) | ₹1,362 Cr | ₹668 Cr |
| Growth | ||
| Latest quarter sales YoY | +12.2% | +10.8% |
| Latest quarter profit YoY | +4.1% | +9.2% |
| Sales CAGR 3Y | +5.0% | +11.0% |
| Profit CAGR 3Y | +8.0% | +31.0% |
| Sales CAGR 5Y | +5.0% | +13.0% |
| Profit CAGR 5Y | +5.0% | +23.0% |
| Financial strength | ||
| Debt/Equity | 0.03 | 0.00 |
| Interest cover | 431.00 | 72.08 |
| Ownership | ||
| Promoter holding | 51.0% | 75.0% |
| Promoter change (4 qtrs) | +0.00 pp | +0.00 pp |
| Price performance | ||
| Return 1M | -2.09% | +5.57% |
| Return 3M | -13.84% | -2.24% |
| Return 1Y | -20.41% | -14.20% |
| Return YTD | -16.65% | -10.67% |
| Technical condition | ||
| Technical score | 48 | 66 |
| RS rating (1-99) | 23.00 | 44.00 |
| % vs 200-DMA | -12.83% | -3.43% |
| RSI (14) | 52.86 | 59.76 |
| % from 52-week high | -24.83% | -17.59% |